HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Functional Insights into Chromatin Remodelling from Studies on CHARGE Syndrome.

Abstract
CHARGE syndrome is a rare genetic syndrome characterised by a unique combination of multiple organ anomalies. Dominant loss-of-function mutations in the gene encoding chromodomain helicase DNA binding protein 7 (CHD7), which is an ATP-dependent chromatin remodeller, have been identified as the cause of CHARGE syndrome. Here, we review recent work aimed at understanding the mechanism of CHD7 function in normal and pathological states, highlighting results from biochemical and in vivo studies. The emerging picture from this work suggests that the mechanisms by which CHD7 fine-tunes gene expression are context specific, consistent with the pleiotropic nature of CHARGE syndrome.
AuthorsM Albert Basson, Conny van Ravenswaaij-Arts
JournalTrends in genetics : TIG (Trends Genet) Vol. 31 Issue 10 Pg. 600-611 (Oct 2015) ISSN: 0168-9525 [Print] England
PMID26411921 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
CopyrightCopyright © 2015 Elsevier Ltd. All rights reserved.
Chemical References
  • Chromatin
  • DNA-Binding Proteins
  • DNA Helicases
  • CHD7 protein, human
Topics
  • CHARGE Syndrome (genetics, pathology)
  • Chromatin (genetics)
  • Chromatin Assembly and Disassembly (genetics)
  • DNA Helicases (biosynthesis, genetics)
  • DNA-Binding Proteins (biosynthesis, genetics)
  • Gene Expression Regulation, Developmental
  • Humans
  • Mutation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: